Drug-labels.com

Q-Montelukast: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current status: Cancelled Pre Market Facts
Strength:
10 mg

Patient Medication Information: uses, side effects, how to take - Q-Montelukast

ABOUT THIS MEDICATION

What the medication is used for:

Asthma (for patients 15 years and older)

Your physician has prescribed Q-MONTELUKAST to treat your asthma, including preventing your asthma symptoms during the day and night. When taken as prescribed, Q-MONTELUKAST also prevents the narrowing of airways triggered by exercise.

Seasonal Allergic Rhinitis (for patients 15 years and older)

Your physician has prescribed Q-MONTELUKAST to treat your seasonal allergies, including daytime and nighttime symptoms, including nasal congestion, runny nose, nasal itching, and sneezing; nasal congestion upon awakening; tearing, itchy, red, and puffy eyes.

What it does:

Q-MONTELUKAST is a leukotriene receptor antagonist that blocks substances in your lungs called leukotrienes. Leukotrienes cause narrowing and swelling of airways in your lungs. Blocking leukotrienes improves asthma symptoms and helps prevent asthma attacks. Leukotrienes also can contribute to the

development of allergy symptoms. Blocking leukotrienes improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).

When it should not be used:

Do not take Q-MONTELUKAST if you are allergic to any of its ingredients. See what the non-medicinal ingredients are.

What the medicinal ingredient is: Montelukast, supplied as Montelukast Sodium.

What the non-medicinal ingredients are:

Each 10 mg film-coated tablet contains the following non-medicinal ingredients: colloidal silicon dioxide, mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, sodium lauryl sulphate. The film-coating consists of: FD&C Yellow #6, FD&C Blue #2,

hydroxypropylmethylcellulose, polydextrose, polyethylene glycol, titanium dioxide, and triacetin.

What dosage forms it comes in:

Q-MONTELUKAST film-coated tablet 10 mg.

WARNINGS AND PRECAUTIONS

Q-MONTELUKAST is not for the treatment of acute asthma attacks. If an attack occurs, you should follow the instructions your physician has given you for that situation.

BEFORE using Q-MONTELUKAST , tell your physician if you:

  • suffer from liver problems;
  • are using any other medicines;
  • have or have had any medical problems or allergies.

You should immediately inform your doctor if you or your child start to have any:

  • agitation, including aggressive behaviour or hostility

    (such as temper tantrums in children),

  • suicidal thoughts and actions,
  • anxiousness, depression (sad mood),
  • disorientation (inability to know correct time, place or person), dream abnormalities, hallucinations (seeing or hearing things that are not there),
  • insomnia, irritability, restlessness, sleep walking,
  • tremors

Use in pregnancy

Women who are pregnant or intend to become pregnant should consult their physician before taking Q-MONTELUKAST .

Use in breast-feeding

It is not known if Q-MONTELUKAST appears in breast milk. You should consult your physician before taking Q-MONTELUKAST if you are breast-feeding or intend to breast-feed.

Q-MONTELUKAST is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with Q-MONTELUKAST may affect some patients' ability to drive or operate machinery.

If your symptoms get worse, you should contact your physician immediately.

If your asthma is made worse by exercise, you should continue to use the medicines your physician has prescribed for you to use before exercise, unless your physician tells you otherwise. You should always have your inhaled rescue medicine for asthma attacks with you in case you need it.

If your asthma is made worse by acetylsalicylic acid (ASA) (e.g., Aspirin®), you should continue to avoid ASA or other non- steroidal anti-inflammatory drugs.

IMPORTANT PLEASE READ

INTERACTIONS WITH THIS MEDICATION

In general, Q-MONTELUKAST does not interfere with other medicines that you may be taking. However, some medicines may affect how Q-MONTELUKAST works, or Q-MONTELUKAST may affect how your other medicines work. It is important to tell your physician about all drugs that you are using or plan to use, including those obtained without a prescription.

PROPER USE OF THIS MEDICATION

Usual dose:

Asthma

Take Q-MONTELUKAST once a day in the evening with or without food, as your physician has prescribed.

Take Q-MONTELUKAST daily for as long as your physician prescribes it in order to maintain control of your asthma. Q-MONTELUKAST can treat your asthma only if you continue to take it.

It is important that you continue taking Q-

MONTELUKAST daily as prescribed by your physician, even when you have no symptoms or if you has an asthma attack.

Seasonal Allergic Rhinitis

Take Q-MONTELUKAST once a day in the evening with or without food, as your physician has prescribed.

Remember that your physician has prescribed this medicine only for you. Never give it to anyone else.

Follow up with your physician to ensure your continued health and safety.

Overdose:

Missed Dose:

Try to take Q-MONTELUKAST as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Any medicine may have unintended or undesirable effects, so- called side effects. MONTELUKAST SODIUM is generally well-tolerated. The most common side effects reported were;

  • abdominal pain
  • headache

    • thirst
    • diarrhea
    • hyperactivity
    • asthma
    • scaly and itchy skin
    • rash

These were usually mild.

Additionally, the following have been reported:

  • upper respiratory tract infection (common cold)
  • feeling anxious, irritability, restlessness, sleep walking, sleep disorders including dream abnormalities and insomnia
  • dizziness, drowsiness, pins and needles/numbness
  • nose bleed
  • joint pain, muscle aches and muscle cramps
  • tender red lumps under the skin, most commonly on your shins
  • weakness/tiredness, fatigue
  • swelling
  • fever

Tell your physician or pharmacist if you develop any of the above symptoms, any unusual symptom, or if any known symptom continues or worsens.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptoms/EffectsTalk with your physician or pharmacistStop taking drug and seek immediate emergency medical attention
Only if severeIn all cases
Rare

symptoms of

allergic reactions such as swelling of the face, lips,

tongue, and/or

throat (which may cause difficulty in breathing or

swallowing), hives, rash, and itching

√
Very Rare

symptoms of liver problems: nausea, vomiting,

fatigue,

jaundice

(yellowing of the skin and eyes), dark urine, flu-like

√

In case of drug overdose, contact a health care practitioner,hospital emergency department or regional Poison ControlCentre immediately, even if there are no symptoms.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
symptoms, loss of appetite, and pain in your abdomen
Very Rareincreased bleeding tendency, bruising√
Very Rare

behavior and mood related changes [agitation including aggressive

behavior or

hostility (such as temper tantrums in children)]

√
Very Raredepression√
Very Raredisorientation (inability to know correct time, place or person)√
Very Raresuicidal thoughts and actions√
Very Raretremor√
Very Rarehallucinations (seeing or hearing things that are not there)√
Very Rare

seizure

(convulsions or fits)

√
Very Rarepalpitations (heart skips a beat)√
Very Rare

a flu-like illness, rash, pins and needles or

numbness of arms or legs, joint pain and severe

sinusitis*

√

*A condition, which includes a combination of certain persistent or worsening symptoms, has been reported very rarely in patients given MONTELUKAST SODIUM. These have occurred usually, but not always, in patients whose oral corticosteroid medicine for asthma is being reduced. Although MONTELUKAST SODIUM has not been shown to cause this condition, you must tell your physician immediately if you experience a combination of these symptoms.

This is not a complete list of side effects. For any unexpected effects while taking Q-MONTELUKAST, contact your physician or pharmacist.

HOW TO STORE IT

Store at controlled room temperature (15°C - 30°C). Protect from moisture and light.

Keep all medicines safely away from children.

HOW TO

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

Report online at www.healthcanada.gc.ca/medeffect Call toll-free at 1-866-234-2345

Complete a Canada Vigilance Reporting Form and: Fax toll-free to 1-866-678-6789, or mail to:

Canada Vigilance Program,

Health Canada

Postal Locator 0701C

Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect

NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full Product Monograph, prepared for health professionals can be found by:

  • contacting the sponsor, QD Pharmaceuticals ULC, at: 1-800-661 3429, or
  • downloading from QD’s Website at:

    www.qdpharmaceuticals.ca

QD Pharmaceuticals ULC

85 Advance Road

Etobicoke, ON M8Z 2S6

January 6, 2012

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02377586

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Q-Montelukast

Rx or OTC
Prescription (Rx)?
DIN 02377586
Schedule(s) PRESCRIPTION
Active ingredient(s) Montelukast (montelukast sodium) 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03D Other systemic drugs for obstructive airway diseases
        1. R03DC Leukotriene receptor antagonists for obstructive airway diseases
          1. R03DC03 Montelukast
Company QD PHARMACEUTICALS ULC
Current status Cancelled Pre Market
Current status date August 21, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.